Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 163,240 | 142,837 | 79,749 | 49,060 | 187,026 |
| Marketable Securities | 320,029 | 309,903 | 424,403 | 309,502 | 143,325 |
| Receivables | 46,923 | 33,284 | 21,962 | 9,464 | 1,304 |
| Inventories | 19,556 | 14,041 | 8,390 | 4,623 | 3,416 |
| TOTAL | $579,469 | $520,073 | $551,096 | $391,965 | $340,064 |
| Non-Current Assets | |||||
| PPE Net | 43,863 | 47,705 | 11,375 | 9,062 | 9,816 |
| Intangibles | 197,797 | 197,797 | 197,797 | 197,797 | 197,797 |
| Other Non-Current Assets | 65,391 | 84,632 | 29,683 | 28,200 | 489,168 |
| TOTAL | $307,051 | $330,134 | $238,855 | $235,059 | $696,781 |
| Total Assets | $886,520 | $850,207 | $789,951 | $627,024 | $1,036,845 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 25,963 | 21,722 | 80,625 | 62,290 | 97,109 |
| Accrued Expenses | 96,841 | 99,901 | N/A | N/A | N/A |
| Other current liabilities | N/A | N/A | 5,500 | 7,750 | 13,850 |
| TOTAL | $129,676 | $128,812 | $86,125 | $70,040 | $110,959 |
| Non-Current Liabilities | |||||
| Long Term Debt | 389,254 | 149,505 | 146,734 | N/A | N/A |
| Other Non-Current Liabilities | 68,908 | 81,508 | 197,559 | 183,513 | 370,058 |
| TOTAL | $470,464 | $244,970 | $360,914 | $204,134 | $565,735 |
| Total Liabilities | $600,140 | $373,782 | $447,039 | $274,174 | $676,694 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 264,316 | 257,245 | 223,709 | 186,891 | 142,741 |
| Common Shares | 2,650 | 2,598 | 1,942 | 1,721 | 1,480 |
| Retained earnings | -2,045,462 | -1,768,610 | -1,412,222 | -1,063,610 | -779,608 |
| Other shareholders' equity | 20,614 | 15,212 | 13,131 | 13,981 | 18,123 |
| TOTAL | $286,380 | $476,425 | $342,912 | $352,850 | $360,151 |
| Total Liabilities And Equity | $886,520 | $850,207 | $789,951 | $627,024 | $1,036,845 |